We studied whether a reduced coronary flow reserve (CFR) in healthy young men independently predicts the presence of coronary artery disease as assessed by coronary artery calcification after 11 years of follow-up.
Introduction
The amount of coronary artery calcium closely correlates with the extent of coronary atherosclerosis. 1, 2 Using cardiac computed tomography (CT), coronary calcification can be quantified as the Agatston coronary calcium score (CCS). 3 Population-based studies have shown that increased CCS predicts future cardiac events including myocardial infarction, resuscitated cardiac arrest and death from coronary artery disease (CAD) in individuals without known cardiovascular disease. 4 A recent study demonstrated that adolescence low-density lipoprotein (LDL) cholesterol levels and blood pressure were significant predictors of the presence of coronary calcium nearly three decades later in the early adulthood. 5 Early stages of CAD are associated with impaired regulation of myocardial blood flow even in the absence of epicardial coronary stenosis. 6 This can be assessed non-invasively by measuring the coronary flow reserve (CFR) with positron emission tomography (PET). 7 -9 The CFR is the ratio of maximal myocardial blood flow during pharmacologically induced hyperaemia to blood flow at rest. It combines coronary flow through both the epicardial arteries and the microcirculation. Abnormally a reduced CFR can be due to either stenosis in the epicardial coronary arteries as well as dysfunction of the coronary microcirculation. 7 -10 In the absence of epicardial coronary stenoses PET with adenosine or dipyridamole enables the assessment of microcirculatory vascular function including the function of both vascular smooth muscle cells and endothelial cells. Among individuals without the evidence of CAD, microvascular dysfunction is related to coronary risk factors, such as hypercholesterolaemia, hypertension, diabetes and smoking. 7 -9,11 -13 It may also predict future vascular events. 7 -9,14,15 Recent cross-sectional studies have shown that a reduced CFR is associated with the presence of coronary calcification in asymptomatic individuals 16, 17 and individuals undergoing myocardial perfusion imaging due to suspicion of CAD. 18 Therefore, it can be hypothesized that a reduced CFR is linked with the future development of coronary atherosclerosis. There are no studies investigating whether a reduced CFR predicts the long-term development of coronary artery calcifications. In the present study we evaluated whether CFR quantified by PET in healthy, lean, normotensive, non-smoking and non-diabetic men at the age of 35 years (baseline) predicts the development of coronary calcifications as assessed by the CCS over 10 years later (at the age of 46 years). In addition, baseline traditional risk factors of CAD were compared with CCS at the end of the follow-up.
Methods

Study population and design
The initial study group consisted of 129 healthy, lean, normotensive, non-smoking, non-diabetic men ageing ≤45 years who underwent myocardial perfusion PET with 15 O-labeled water at rest and during dipyridamole or adenosine stress at baseline at the age of 35.3 + 3.9 years. The study group was formed from a healthy control group in two studies that have been reported earlier. 12, 13 Individuals with a body mass index of .27 kg/m 2 , blood pressure of .150/90 mmHg, serum fasting glucose of .6.0 mmol/L, or history of atherosclerotic disease were excluded. Individuals were invited for the follow-up study for 11 + 1 years after the baseline study where CCS scan, CAD risk factors, and medication were screened by interview and blood tests. Blood pressure was measured with the electronic oscillometric hand cuff method. Stress echocardiography was performed to a subgroup of individuals (12 with CCS .0 and 15 individuals with CCS ¼ 0). In the follow-up 52 individuals were lost. One had died of non-cardiac cause and the others either could not be contacted (n ¼ 25) or refused to participate (n ¼ 26). Thus, the final study population consisted of 77 individuals who underwent the measurement of CCS with CT at the end of the follow-up at the age of 46 + 4 years.
The study was performed according to the Declaration of Helsinki and it was approved by the local Ethics Committee. Individuals gave informed written consent for both baseline and follow-up studies. Additional radiation dose was 1 mSv from CT scan.
Positron emission tomography
PET studies were performed after an overnight fast. Alcohol and caffeine were prohibited 12 h before the study. Myocardial blood flow was measured before and after the administration of adenosine (n ¼ 42) or dipyridamole (n ¼ 35). For the production of 15 O, a lowenergy deuteron accelerator Cyclone 3 was used (Ion Beam Application, Louvain-la-Neuve, Belgium). 15 O-labeled water was produced using dialysis techniques in a continuously working water module.
Values of blood flow were expressed in millilitres/minute/gram. CFR was defined as the ratio of myocardial blood flow after dipyridamole or adenosine to flow at baseline. Rate-pressure product is defined as a systolic blood pressure multiplied by heart rate. Myocardial vascular resistance was calculated by dividing the mean blood pressure by myocardial blood flow. These variables were used to assess the haemodynamic reaction to adenosine and dipyridamole. The PET protocol has been reported in detail in the previous articles.
11 ,12 Based on our recent observations that stress myocardial blood flow is ,2.5 ml/g/min in the presence of significant coronary stenosis, individuals were also grouped into normal and abnormal flow according to this threshold. 19 
Measurement of CCS
CCS scan was performed with a 64-row PET/CT scanner (GE Discovery VCT, General Electric Medical Systems, Waukesha, WI, USA). The tube voltage was 120 kV, tube current 200 mA, rotation time 400 ms and collimation 16 × 2.5 mm. Data were acquired using a prospective ECG-triggering at 70% of the R -R interval. CCS was quantified as described by Agatston et al. 3 using commercially available software (SmartScore, GE Healthcare). CCS obtained in the left main, left anterior descending, left circumflex and right coronary artery and then combined to form the total CCS.
Laboratory tests
Venous blood tests were taken after an overnight fast. Serum total cholesterol, triglycerides and HDL cholesterol were measured with standard enzymatic methods (Boehringer Mannheim GmbH) with a fully automated analyser (Hitachi 704; Hitachi Ltd, Tokyo, Japan). LDL cholesterol concentration was calculated with the Friedwald formula. The serum glucose concentration was determined by the enzymatic hexokinase method (Glucose reagent, Olympus). Serum creatinine concentration was measured by standard photometric methods (Olympus Diagnostica GmbH, Hamburg, Germany) and by Konelab 60i Clinical Chemistry Analyzer (Thermo Electron Co, Finland).
Echocardiography and stress echocardiography
Acuson 128XP/10 or Sequoia 512 (Acuson, Inc., Mountain View, CA, USA) equipped with 2.5/3.5 MHz phased-arrayed transducer was used in echocardiographic imaging as we have previously described. 20 In stress echocardiocgraphy bicycle exercise was applied.
Statistical analysis
The mean and the standard deviation were calculated for variables. Normally distributed variables were compared using the non-paired t-test and other variables with the non-parametric Mann-Whitney U test. Multivariate logistic regression analysis was used to study the associations of CFR, lipids, blood pressure and body mass index at
Coronary flow reserve and development of coronary calcifications baseline with the outcome of CCS (CCS ¼ 0 or CCS .0). Because ageing is known to be associated with coronary calcification, age at the time of CT scan was included in the model as a variable and other variables were normalized for age at the time of PET study. Assuming a mean CFR of 4.1 + 1.3, a sample of 77 individuals is enough to detect a difference of 6% in CFR (Johannson et al.
21
) with a power of 90% and a confidence level of ,0.05.
Two-tailed P-values of ,0.05 were considered statistically significant. Statistical analyses were done using SPSS (SPSS, Inc., Chicago, IL, USA).
Results
The study group consisted of 77 healthy, lean, normotensive, nondiabetic and non-smoking men aged 36 + 4 years at the time of the PET perfusion studies. The basic characteristics of participants are shown in Table 1 . None of the participants had symptomatic cardiovascular disease. None of the patients had medication for cardiovascular risk factors at baseline, but 16 were treated for hypertension, hypercholesterolaemia or diabetes at the end-of the follow-up as shown in Table 1 .
The average myocardial blood flow was 0.79 + 0.2 ml/g/min at rest and increased to 3.3 + 1.2 ml/g/min during adenosine or dipyridamole-induced vasodilatation (P , 0.001 vs. rest). Thus, the average CFR was 4.1 + 1.3. There were 22 individuals with the myocardial blood flow ,2.5 ml/g/min after dipyridamole or adenosine and 6 individuals with the CFR ,2.5. The rate-pressure product was on average 7555 + 1605 mmHg/min at rest and increased to 10 776 + 2535 mmHg/min after adenosine or dipyridamole. Thus, the average myocardial vascular resistance was 115 + 29 mmHg*min*g/ml at rest and reduced to 32 + 20 mmHg*min*g/ml after adenosine or dipyridamole.
CFR and baseline characteristics
There were no relationship between CFR and coronary risk factors at the time of the PET study. As shown in Table 2 , age, BMI, systolic and diastolic blood pressure, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides and fasting glucose were comparable between individuals with CFR lower or higher than the median (4.0) of the group. Furthermore, in a subset of participants who had echocardiography at baseline there was no difference in the LV mass between the individuals with the CFR 
Individuals with cardiovascular medication (n) 0 1 6
Statin medication (n) 0 1 0 Individuals with antihypertensive medication (n) 0 8
Beta-blocker (n) 0 2 ACE inhibitor/AT2-antagonist (n) 0 7 Calcium-channel blocker (n) 0 3
Diagnosis of diabetes (n) 0 2
Data are presented as the mean + SD. CCS, coronary calcium score; CFR, coronary flow reserve; BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ACE, angiotensin-converting enzyme; AT2, angiotensin 2 receptor; n, number.
Coronary artery calcium score and follow-up characteristics
The prevalence of coronary artery calcium (CCS .0) was 39% at an age of 46 + 4 years. The mean CCS of the 77 individuals was 25.2 + 65.6 and 64.7 + 93.0 in individuals with CCS .0. The distribution of CCS is shown in Figure 1A .
At the end of the follow-up, the presence of CCS (CCS .0) was associated with higher systolic and diastolic blood pressures as shown in Table 3 . However, the presence of CCS was not related to other coronary risk factors ( Table 3) . CCS was also comparable in smokers and non-smokers (7 smokers, 9 + 18 vs. 27 + 70, P ¼ 0.10) as well as in patients on medical therapy for hypertension, cholesterol or diabetes (16 had medical therapy, 42 + 84 vs. 21 + 60, P ¼ 0.27). None of the individuals had inducible wall motion abnormalities indicating myocardial ischaemia in stress echocardiography.
Baseline predictors of coronary artery calcium score
There was no correlation between CCS at follow-up and myocardial blood flow at the time of PET study ( Figure 1B and C) .
Myocardial blood flow was comparable in individuals with CCS ¼ 0 or CCS .0 both at rest (0.8 + 0.2 vs. 0.8 + 0.2 ml/g/ min, P ¼ 0.79, Figure 1D ) and during stress (3.3 + 1.2 vs. 3.3 + 1.2 ml/g/min, P ¼ 0.99, Figure 1D ).
Baseline CFR was not related to CCS at follow-up as shown in Figure 1C . The average CFR was comparable in individuals who had CCS ¼ 0 when compared with those with CCS .0 (4.0 + 1.2 vs. 4.2 + 1.4, P ¼ 0.44, Figure 1D ). There were no correlation between CFR and CCS even when patients with .20 mmHg increase in blood pressure (n ¼ 19, r ¼ 0.19, P ¼ 0.21) or .1 mmol/L change in total cholesterol (n ¼ 26, r ¼ 0.02, P ¼ 0.89) during the follow-up were excluded. Similarly, CCS was comparable in individuals who had impaired stress myocardial blood flow (,2.5 ml/g/min, P ¼ 22) and normal stress flow (≥2.5, n ¼ 58) at baseline (23 + 61 vs. 26 + 68, P ¼ 0.79). There were only six individuals with CFR ,2.5 of whom three had coronary calcification. There were no differences in the haemodynamic response to adenosine and dipyridamole in individuals with and without coronary artery calcification.
As shown in Table 3 , the coronary risk factors including blood pressure, cholesterol levels and blood glucose were comparable in individuals with CCS .0 and CCS ¼ 0 at the time of the PET study. CCS was comparable in individuals with the total plasma cholesterol .5.0 (n ¼ 46) or ≤5.0 (n ¼ 31) mmol/L at baseline (26 + 71 vs. 25 + 58, P ¼ 0.95), whereas CCS was higher in individuals with systolic blood pressure .130 (n ¼ 24) than ≤130 (n ¼ 56) mmHg at baseline (41 + 71 vs. 18 + 62, P ¼ 0.012). Multivariable logistic regression analysis (Table 4) showed that CFR, systolic blood pressure, total cholesterol, BMI at the time of the PET study were not significantly associated with CCS (P . 0.05).
Discussion
We found that CFR as measured by 15 O water myocardial perfusion PET was not predictive of CCS in healthy, lean, normotensive, non-smoking and non-diabetic young men. These results suggest that in asymptomatic men with a very low likelihood of CAD, microvascular dysfunction is not a strong predictor of future coronary artery calcification. Alterations in the endothelial function have been demonstrated to precede the development of atherosclerotic changes in the clinical and experimental studies. original hypothesis, however, there was no relationship between coronary vasodilator function and coronary calcification at the end of the follow-up. Several potential mechanisms that could explain the lack of relationship between CFR and calcification in this study are discussed below. Although it has been suggested that microvascular dysfunction is a key event preceding the development of atherosclerosis, the relationship between functional changes and anatomical features of atherosclerosis may not be straightforward as they may reflect the different aspects of pathophysiology. 16,23 -25 Although CCS is an established marker of the presence of coronary atherosclerosis, 1 -4 it does not provide the characterization of atherosclerotic plaques and actually may preferentially detect stable, calcified lesions. In order to focus this study on the independent relationship of CFR and coronary calcification we selected healthy individuals without confounding effects of risk factors that are known to cause microvascular dysfunction, including diabetes, hypertension, familial hypercholesterolaemia and smoking. Thus, the number of individuals with microvascular dysfunction as well as the likelihood of CAD was small in this population. Compared with the previous cross-sectional studies comparing CFR and calcification, individuals in our study were much younger and had much lower CCS. The mean CCS was 25 + 66 in our study, 249 + 528 in the study of Curillova et al. and 237 + 256 in the study of Pirich et al. 16, 18 In the study of Wang et al., 17 57 of the 222 individuals had CCS
.100. There might be a significant overlap of risk factors for anatomical and functional changes in CAD. Therefore, it is of great importance to study the relationship of functional and anatomical changes of atherosclerosis in a study population with minimal risk factors for vascular disease. Our study group is selected and this may explain the lack of correlation between many of the traditional risk factors of CAD and coronary calcification. Although risk factors of CAD at baseline were comparable between patients with or without coronary calcification, we cannot exclude the possibility that there have been changes in lifestyle during the follow-up that have confounded the association between CFR and development of coronary calcifications. However, there was no association between CFR and calcifications even when the patients with increase in blood pressure or change in total cholesterol during the follow-up were excluded from the analysis. In small number of individuals who had anti-hypertensive, cholesterol lowering or glucose lowering medication at the end of the study, CCS was comparable with the others. We cannot exclude the possible bias related to the relatively large number of individuals that did not participate in this follow-up study.
Measurement of CCS is a highly standardized and reproducible technique. 26 Quantitative measurement of global myocardial blood flow with PET and 15 O-labeled water was well validated and highly reproducible at the time this study was performed. 11 -13,19 No difference in the responses to adenosine or dipyridamole were detected which is in agreement with previous studies. 27 Response to cold pressor test could have been more sensitive to detect abnormal endothelial function. 8 Epicardial coronary stenosis could influence the relationship between perfusion and CCS. Coronary angiography was not done because it was clinically unjustified in our individuals with low risk for CAD. However, regional perfusion was homogenous in all of our individuals and the subgroup undergoing stress echocardiography had no evidence of ischaemia. Due to logistic reasons only less than half of the patients with CCS .0 underwent stress echocardiography. Measurement of CCS was not available at baseline and PET perfusion was not measured during the follow-up that could have provided additional information on the relationships between CFR and CCS in our study populations.
Conclusions
Coronary reactivity to adenosine or dipyridamole-induced hyperaemia as assessed by perfusion PET was not predictive of the presence of coronary calcification after 11 years of follow-up in asymptomatic men with a very low likelihood of CAD. 
